Buy RU-28306 Cas 73625-11-3
Buy RU-28306 Cas 73625-11-3
RU-28306, also known as 4,α-methylene-N,N-dimethyltryptamine (4,α-methylene-DMT), is a synthetic indole alkaloid derivative which acts as a serotonin receptor agonist, with selectivity for 5-HT1 and 5-HT2 subtypes. It can be regarded as a conformationally restricted tricyclic derivative of DMT or a structurally simplified derivative of LSD. The binding affinity of racemic RU-28306 is closer to that of DMT than LSD, though with relatively higher affinity for 5-HT2 subtypes and lower for 5-HT1.[1][2] It has been sold as a designer drug and was first reported to the EMCDDA by a forensic laboratory in Slovenia in 2017.[3] It was subsequently patented by Delix Therapeutics in 2021.[4]
Reviews
There are no reviews yet.